More recently, a protective role of ABHD6 for the treatment of MS was investigated by Manterola et al. in two studies revising the role of ABHD6 in the cuprizone model of non-immune-dependent demyelination and in EAE [54,55]. Here, ABHD6 is linked to myeloid sarcoma.